Sign Up Today and Learn More About Alto Neuroscience Stock
Invest in or calculate the value of your shares in Alto Neuroscience or other pre-IPO companies through EquityZen's platform.
Alto Neuroscience Stock
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
About Alto Neuroscience Stock
Founded
2019
Headquarters
Los Altos, CA, US
Industries
Alto Neuroscience Press Mentions
Stay in the know about the latest news on Alto Neuroscience
Alto Neuroscience, Fractyl Health Join IPO Surge with Detailed Offering Plans
biospace • Feb 05, 2024
Alto Neuroscience Announces Pricing of Upsized Initial Public Offering
businesswire • Feb 05, 2024
CNS disorder biotech Alto Neuroscience prices upsized IPO at $16, the high end of the range
renaissancecapital • Feb 03, 2024
Alto Neuroscience 8.04M share IPO priced at $16.00
thefly • Feb 02, 2024
Biotechnology company Alto Neuroscience sets terms to head to Wall Street
bizjournals • Jan 30, 2024
Alto Neuroscience Management
Leadership team at Alto Neuroscience
Chief Medical Officer
Adam Savitz
Vice President, Clinical Operations
Lesley Parker
Join now and verify your accreditation status to gain access to:
- Alto Neuroscience current valuation
- Alto Neuroscience stock price
- Available deals in Alto Neuroscience and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Alto Neuroscience stock?
Accredited investors can buy pre-IPO stock in companies like Alto Neuroscience through EquityZen funds. These investments are made available by existing Alto Neuroscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Alto Neuroscience stock?
Shareholders can sell their Alto Neuroscience stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
